TY - JOUR T1 - COVID-19 necrotising pneumonia and extracorporeal membrane oxygenation: a challenge for anticoagulation JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00182-2020 VL - 6 IS - 2 SP - 00182-2020 AU - Suzanne Goursaud AU - Martin Mombrun AU - Damien du Cheyron Y1 - 2020/04/01 UR - http://openres.ersjournals.com/content/6/2/00182-2020.abstract N2 - Extracorporeal membrane oxygenation (ECMO) support is proposed as rescue therapy for severe acute respiratory distress syndrome (ARDS) related to coronavirus disease 2019 (COVID-19) [1]. Severe bleeding events were described in severe ARDS patients requiring ECMO in large cohorts [2]. Few studies reported their experiences in COVID-19 critically ill patients receiving ECMO [3]. However, Yang et al. [4] highlighted in their retrospective cohort a high mortality rate in these patients. We report a severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) necrotising pneumonia-induced fatal haemorrhagic complication with ECMO.ECMO and curative anticoagulation may be associated with severe bleeding events in #COVID19 pneumonia. ECMO and high levels of anticoagulation must be considered with caution in the most severe patients with #SARS-CoV-2 necrotising pneumonia. https://bit.ly/3clhu31The authors declare they have obtained the patient's next of kin consent for the publication. ER -